Fiber also promotes longer-lasting fullness compared to low-fiber foods
Although several observational real-world studies of semaglutide OW have been undertaken [21,22,23,24,25,26,27,28,29,30,31], evidence concerning its relative effectiveness versus other interventions (including SGLT2is) in the real-world setting is limited
Treatment with semaglutide tablets 14 mg once daily for 26 weeks resulted in a statistically significant reduction in HbA1c from baseline compared to placebo (see Table 8)
In a pivotal year-long trial, individuals undergoing semaglutide treatment experienced an average weight loss of 14.9%, with approximately one-third achieving an impressive weight reduction exceeding 20% (PubMed)